Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 12,273,280 | reported | 17 Apr 2025 | tx 5+7,407,408−1,851,852 |
| GENOCEA BIOSCIENCES, INC. | 7,225,676 | reported | 24 Jun 2019 | tx 3+15,292,478 |
| TAPIMMUNE INC | 1,625,678 | reported | 23 Dec 2024 | tx 2+6,268,535 |
| Mirum Pharmaceuticals, Inc. | 30,000 | reported | 13 Jun 2023 | tx 3+30,000−2,030,000 |
| Metacrine, Inc. | 0 | reported | 18 Sept 2020 | tx 5+3,060,527−2,291,297 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Apr 2025 | EXERCISE | Trevi Therapeutics, Inc. | 1,851,852 | 1.37 USD | |
| 17 Apr 2025 | EXERCISE | Trevi Therapeutics, Inc. | 1,851,852 | 0.00 USD | deriv |
| 23 Dec 2024 | PURCHASE | TAPIMMUNE INC | 554,250 | 3.20 USD | first after silence |
| 13 Jun 2023 | OTHER | Mirum Pharmaceuticals, Inc. | 30,000 | 0.00 USD | |
| 13 Jun 2023 | OTHER | Mirum Pharmaceuticals, Inc. | 30,000 | 0.00 USD | |
| 13 Jun 2023 | OTHER | Mirum Pharmaceuticals, Inc. | 2,000,000 | 0.00 USD | |
| 18 Oct 2021 | PURCHASE | Trevi Therapeutics, Inc. | 1,851,852 | — | |
| 18 Oct 2021 | PURCHASE | Trevi Therapeutics, Inc. | 1,851,852 | — | deriv |
| 18 Oct 2021 | PURCHASE | Trevi Therapeutics, Inc. | 1,851,852 | — | deriv |
| 16 Mar 2021 | PURCHASE | TAPIMMUNE INC | 5,714,285 | 1.75 USD | |
| 18 Sept 2020 | CONVERSION | Metacrine, Inc. | 1,958,333 | — | |
| 18 Sept 2020 | PURCHASE | Metacrine, Inc. | 769,230 | 13.00 USD | first after silence |
| 18 Sept 2020 | CONVERSION | Metacrine, Inc. | 332,964 | — | |
| 18 Sept 2020 | CONVERSION | Metacrine, Inc. | 332,964 | 0.00 USD | deriv |
| 18 Sept 2020 | CONVERSION | Metacrine, Inc. | 1,958,333 | 0.00 USD | deriv |
| 24 Jun 2019 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 2,857,142 | 3.50 USD | |
| 14 Feb 2019 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 9,948,269 | 0.47 USD | |
| 14 Feb 2019 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 2,487,067 | 0.13 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 23 Dec 2024.